EDIGENE INC.

ADAR

Cells for medical or clinical use; pharmaceutical preparations in the nature of genetically modified therapeutic pharmaceuticals for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological, hematologic and viral diseases and disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations in the nature of genetically modified therapeutic pharmaceuticals, namely, antifungal preparations, dermatological preparations, smoking cessation preparations and tissue repair preparations in the nature of biological tissue grafts; diagnostic reagents for medicinal use;Medical and scientific research in the field of genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; medical and scientific research information in the field of genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; pharmaceutical research and development; pharmaceutical research services; providing medical and scientific research information in the fields of pharmaceuticals and genetics;

ARRNA

Cells for medical or clinical use; pharmaceutical preparations in the nature of genetically modified therapeutic pharmaceuticals for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological, hematologic and viral diseases and disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations in the nature of genetically modified therapeutic pharmaceuticals, namely, antifungal preparations, medicated dermatological preparations and substances, smoking cessation preparations and tissue repair preparations in the nature of biological tissue grafts; diagnostic reagents for medicinal use;Medical and scientific research in the field of genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; medical and scientific research information in the field of genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; pharmaceutical research and development; pharmaceutical research services; providing medical and scientific research information in the fields of pharmaceuticals and genetics;

EDIGENE

Biological preparations for medical purposes; styptic preparations; medicines for human purposes; pharmaceutical preparations; stem cells for medical purposes; surgical implants comprised of living tissues; blood products; biological preparations for the treatment of cancer; pharmaceutical preparations for activating cellular function; cytostatics for medical purposes; living cells for medical purposes; ophthalmological preparations; pharmaceutical preparations for ophthalmological use; cord blood for medical purposes;Biotechnology research; scientific research for medical purposes in the area of cancerous diseases; genetic testing for scientific research purposes; structural and functional analysis of genomes; DNA screening for scientific research purposes; conducting early evaluations in the field of new pharmaceuticals; pharmaceutical research services; analysis of the mode of action of chemical combinations on animals; technological research; scientific laboratory services; chemical research; biological research; clinical trials; medical research;

EDIGENE

The mark consists of the stylized wording EDIGENE.;Biological preparations for medical purposes; styptic preparations; medicines for human purposes; pharmaceutical preparations; stem cells for medical purposes; surgical implants comprised of living tissues; blood for medical purposes; biological preparations for the treatment of cancer; pharmaceutical preparations for activating cellular function; cytostatics for medical purposes; living cells for medical use; ophthalmological preparations; pharmaceutical products for ophthalmological use; cord blood for medical purposes;Biotechnology research; scientific research for medical purposes in the area of cancerous diseases; genetic testing for scientific research purposes; structural and functional analysis of genomes; DNA screening for scientific research purposes; conducting early evaluations in the field of new pharmaceuticals; pharmaceutical research services; analysis of the mode of action of chemical combinations on animals; technological research; scientific laboratory services; chemical research; biological research; clinical trials; medical research;